NO20032938D0 - Kvatern¶re ammoniumforbindelser - Google Patents
Kvatern¶re ammoniumforbindelserInfo
- Publication number
- NO20032938D0 NO20032938D0 NO20032938A NO20032938A NO20032938D0 NO 20032938 D0 NO20032938 D0 NO 20032938D0 NO 20032938 A NO20032938 A NO 20032938A NO 20032938 A NO20032938 A NO 20032938A NO 20032938 D0 NO20032938 D0 NO 20032938D0
- Authority
- NO
- Norway
- Prior art keywords
- quaternary ammonium
- ammonium compounds
- trifluoromethyl
- compound
- methyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C215/48—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups
- C07C215/54—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C215/66—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with quaternised amino groups bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
- C07C217/62—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C219/26—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C219/28—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton having amino groups bound to acyclic carbon atoms of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
- C07C237/30—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to hydrogen atoms or to acyclic carbon atoms
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34893001P | 2001-10-26 | 2001-10-26 | |
| US36197902P | 2002-03-06 | 2002-03-06 | |
| US39152102P | 2002-06-25 | 2002-06-25 | |
| PCT/US2002/034529 WO2003035599A1 (en) | 2001-10-26 | 2002-10-25 | Quarternary ammonium compounds and their use as antimuscarinic agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20032938D0 true NO20032938D0 (no) | 2003-06-26 |
| NO20032938L NO20032938L (no) | 2003-08-25 |
Family
ID=27407868
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20032938A NO20032938L (no) | 2001-10-26 | 2003-06-26 | Kvatern¶re ammoniumforbindelser samt deres anvendelse som anti-muskariniskemidler |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US6890920B2 (no) |
| EP (1) | EP1461306B1 (no) |
| JP (1) | JP3981357B2 (no) |
| AT (1) | ATE418534T1 (no) |
| BR (1) | BR0206207A (no) |
| CA (1) | CA2464223C (no) |
| CY (1) | CY1109898T1 (no) |
| DE (1) | DE60230546D1 (no) |
| DK (1) | DK1461306T3 (no) |
| ES (1) | ES2315425T3 (no) |
| MX (1) | MXPA04003865A (no) |
| MY (1) | MY130316A (no) |
| NO (1) | NO20032938L (no) |
| PT (1) | PT1461306E (no) |
| SG (1) | SG168451A1 (no) |
| WO (1) | WO2003035599A1 (no) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0957073A1 (en) | 1998-05-12 | 1999-11-17 | Schwarz Pharma Ag | Novel derivatives of 3,3-diphenylpropylamines |
| ATE418534T1 (de) * | 2001-10-26 | 2009-01-15 | Pharmacia & Upjohn Co Llc | Quaternäre ammoniumverbindungen und deren verwendung als antimuscarinische wirkstoffe |
| US7754242B2 (en) * | 2002-03-20 | 2010-07-13 | Alkermes, Inc. | Inhalable sustained therapeutic formulations |
| EP1499300B1 (en) * | 2002-04-29 | 2009-03-18 | Supernus Pharmaceuticals, Inc. | Pharmaceutical formulations with improved bioavailability |
| DE10315917A1 (de) * | 2003-04-08 | 2004-11-18 | Schwarz Pharma Ag | Hochreine Basen von 3,3-Diphenylpropylaminmonoestern |
| EP1622606A1 (en) * | 2003-04-15 | 2006-02-08 | Pharmacia & Upjohn Company LLC | Quaternary ammonium compounds and their use as antimuscarinic agents |
| WO2004091597A2 (en) * | 2003-04-15 | 2004-10-28 | Pharmacia & Upjohn Company Llc | Method of treating irritable bowel syndrome (ibs) |
| WO2004091596A2 (en) * | 2003-04-18 | 2004-10-28 | Pharmacia & Upjohn Company Llc | Combination therapies for chronic obstructive pulmonary disease (copd) |
| BRPI0409653A (pt) | 2003-04-25 | 2006-04-25 | Pharmacia & Upjohn Co Llc | 3,3-difenilpropilaminas (tolterodina) substituìdas com halogênio com atividade antimuscarìnica |
| JP5610663B2 (ja) | 2003-11-04 | 2014-10-22 | スパーナス ファーマシューティカルズ インコーポレイテッド | トロスピウムの１日１回剤形 |
| WO2005046663A1 (en) | 2003-11-04 | 2005-05-26 | Shire Laboratories, Inc. | Compositions of quaternary ammonium containing bioavailability enhancers |
| ES2235648B1 (es) * | 2003-12-22 | 2006-11-01 | Ragactives, S.L. | Procedimiento para la obtencion de tolterodina. |
| EP1701932B1 (en) | 2003-12-24 | 2012-07-18 | Cipla Ltd. | Tolterodine, compositions and uses thereof, and preparation of the same |
| EP1751089A4 (en) * | 2004-03-11 | 2010-03-10 | Glaxo Group Ltd | NEW M3 MUSCARIN ACETYLCHOLINE RECEPTOR ANTAGONISTS |
| EP1838659B1 (en) * | 2004-12-24 | 2015-07-15 | LEK Pharmaceuticals d.d. | Process for preparation of n,n-diisopropyl-3-(2-hydroxy-5-methylphenyl)-3-phenylpropylamine |
| WO2007134964A1 (en) * | 2006-05-24 | 2007-11-29 | Boehringer Ingelheim International Gmbh | Novel medicament combinations for the treatment of respiratory diseases |
| EP1908502A1 (en) * | 2006-10-02 | 2008-04-09 | Koninklijke Philips Electronics N.V. | Interactive modular tile system |
| US7731604B2 (en) * | 2006-10-31 | 2010-06-08 | Taylor Made Golf Company, Inc. | Golf club iron head |
| US20100112061A1 (en) * | 2006-12-13 | 2010-05-06 | William Baker | Monophosphates as Mutual Prodrugs of Muscarinic Receptor Antagonists and Beta-Agonists for the Treatment of COPD And Chronic Bronchitis |
| CA2675942C (en) * | 2007-02-23 | 2016-04-12 | Theravance, Inc. | Quaternary ammonium diphenylmethyl compounds useful as muscarinic receptor antagonists |
| US8202891B2 (en) * | 2007-04-24 | 2012-06-19 | Theravance, Inc. | Quaternary ammonium compounds useful as muscarinic receptor antagonists |
| US20090246146A1 (en) * | 2008-01-25 | 2009-10-01 | Botond Banfi | Halides in the treatment of pathogenic infection |
| WO2009152171A1 (en) * | 2008-06-10 | 2009-12-17 | Gilead Sciences, Inc. | Corticosteroid linked beta-agonist compounds for use in therapy |
| EP2323967A2 (en) * | 2008-07-21 | 2011-05-25 | Actavis Group PTC EHF | Fesoterodine comprising a reduced amount of dehydroxyfesoterodine |
| JP5801997B2 (ja) | 2009-07-07 | 2015-10-28 | ファイザー・リミテッドＰｆｉｚｅｒ Ｌｉｍｉｔｅｄ | 薬品の組合せを吸入するための投薬ユニット、投薬ユニットのパック、および吸入器 |
| CN110372571B (zh) * | 2018-04-12 | 2022-11-15 | 中国科学院大连化学物理研究所 | 一种2-(2,2-二芳基乙基)-环胺衍生物或盐及合成和应用与组合物 |
| CN110845357B (zh) * | 2019-11-22 | 2022-09-30 | 华东理工大学 | 季铵盐型酰肼化合物及由其制备的季铵盐型腙类化合物与应用 |
| AU2021296221A1 (en) | 2020-06-26 | 2023-02-02 | Mylan Pharma Uk Limited | Formulations including 5-(3-(3-hydroxyphenoxy)azetidin-1-yl)-5-methyl-2,2-diphenylhexanamide |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE106643C (no) | ||||
| US2592191A (en) * | 1949-09-16 | 1952-04-08 | Sterling Drug Inc | Quaternary ammonium salts of nu-(3, 3-diphenylpropyl) pyrrolidine |
| NL267508A (no) | 1960-07-26 | |||
| NL6717123A (no) * | 1966-12-29 | 1968-07-01 | ||
| US3505337A (en) * | 1967-12-22 | 1970-04-07 | Boehringer Sohn Ingelheim | N - hydrocarbyl-substituted noratropinium,haloalkylates and o-acyl derivatives thereof |
| US5382600A (en) * | 1988-01-22 | 1995-01-17 | Pharmacia Aktiebolag | 3,3-diphenylpropylamines and pharmaceutical compositions thereof |
| IL91377A (en) * | 1988-09-14 | 1996-09-12 | Nippon Shinyaku Co Ltd | Derivatives of botinylamine glycolate |
| GB8906166D0 (en) * | 1989-03-17 | 1989-05-04 | Pfizer Ltd | Therapeutic agents |
| DE3931041C2 (de) | 1989-09-16 | 2000-04-06 | Boehringer Ingelheim Kg | Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel |
| SE9203318D0 (sv) * | 1992-11-06 | 1992-11-06 | Kabi Pharmacia Ab | Novel 3,3-diphenylpropylamines, their use and preparation |
| US5492933A (en) | 1993-10-08 | 1996-02-20 | Sepracor, Inc. | Methods and compositions for treating urinary incontinence and other disorders using optically pure R-terodiline and hydroxylated derivatives thereof |
| AU7971394A (en) | 1993-10-08 | 1995-05-04 | Sepracor, Inc. | Method for treating urinary incontinence using optically pure s-terodiline |
| KR20000057548A (ko) | 1996-12-13 | 2000-09-25 | 알프레드 엘. 미첼슨 | 광학적 전송물질 및 결합재 |
| SE9701144D0 (sv) | 1997-03-27 | 1997-03-27 | Pharmacia & Upjohn Ab | Novel compounds, their use and preparation |
| PE20020547A1 (es) * | 2000-10-24 | 2002-06-12 | Upjohn Co | Uso de la tolterodina en tratamientos del asma |
| EP1332377A1 (en) | 2000-10-26 | 2003-08-06 | Koninklijke Philips Electronics N.V. | Electronic device |
| ATE418534T1 (de) * | 2001-10-26 | 2009-01-15 | Pharmacia & Upjohn Co Llc | Quaternäre ammoniumverbindungen und deren verwendung als antimuscarinische wirkstoffe |
| EP1622606A1 (en) * | 2003-04-15 | 2006-02-08 | Pharmacia & Upjohn Company LLC | Quaternary ammonium compounds and their use as antimuscarinic agents |
| BRPI0409653A (pt) * | 2003-04-25 | 2006-04-25 | Pharmacia & Upjohn Co Llc | 3,3-difenilpropilaminas (tolterodina) substituìdas com halogênio com atividade antimuscarìnica |
-
2002
- 2002-10-25 AT AT02793840T patent/ATE418534T1/de active
- 2002-10-25 DK DK02793840T patent/DK1461306T3/da active
- 2002-10-25 US US10/280,906 patent/US6890920B2/en not_active Expired - Fee Related
- 2002-10-25 SG SG200905309-1A patent/SG168451A1/en unknown
- 2002-10-25 JP JP2003538115A patent/JP3981357B2/ja not_active Expired - Fee Related
- 2002-10-25 ES ES02793840T patent/ES2315425T3/es not_active Expired - Lifetime
- 2002-10-25 WO PCT/US2002/034529 patent/WO2003035599A1/en active Application Filing
- 2002-10-25 MY MYPI20024003A patent/MY130316A/en unknown
- 2002-10-25 PT PT02793840T patent/PT1461306E/pt unknown
- 2002-10-25 EP EP02793840A patent/EP1461306B1/en not_active Expired - Lifetime
- 2002-10-25 DE DE60230546T patent/DE60230546D1/de not_active Expired - Lifetime
- 2002-10-25 MX MXPA04003865A patent/MXPA04003865A/es active IP Right Grant
- 2002-10-25 BR BR0206207-0A patent/BR0206207A/pt not_active Application Discontinuation
- 2002-10-25 CA CA002464223A patent/CA2464223C/en not_active Expired - Fee Related
-
2003
- 2003-06-26 NO NO20032938A patent/NO20032938L/no not_active Application Discontinuation
-
2005
- 2005-03-08 US US11/074,914 patent/US7439397B2/en not_active Expired - Fee Related
-
2009
- 2009-02-03 CY CY20091100122T patent/CY1109898T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003035599A1 (en) | 2003-05-01 |
| MY130316A (en) | 2007-06-29 |
| SG168451A1 (en) | 2011-02-28 |
| CA2464223A1 (en) | 2003-05-01 |
| ATE418534T1 (de) | 2009-01-15 |
| EP1461306A1 (en) | 2004-09-29 |
| DE60230546D1 (de) | 2009-02-05 |
| US20030158176A1 (en) | 2003-08-21 |
| CY1109898T1 (el) | 2014-09-10 |
| JP3981357B2 (ja) | 2007-09-26 |
| MXPA04003865A (es) | 2004-07-08 |
| BR0206207A (pt) | 2003-12-23 |
| NO20032938L (no) | 2003-08-25 |
| US20050148672A1 (en) | 2005-07-07 |
| CA2464223C (en) | 2009-05-26 |
| US6890920B2 (en) | 2005-05-10 |
| DK1461306T3 (da) | 2009-03-09 |
| US7439397B2 (en) | 2008-10-21 |
| PT1461306E (pt) | 2009-04-01 |
| EP1461306B1 (en) | 2008-12-24 |
| JP2005524605A (ja) | 2005-08-18 |
| ES2315425T3 (es) | 2009-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20032938D0 (no) | Kvatern¶re ammoniumforbindelser | |
| NO20171811A1 (no) | Fremgangsmåte for fremstilling av (1R,2R)-3-(3-dimetylamino-1-etyl-2-metyl-propyl)-fenol | |
| BR122012009534B8 (pt) | 4-[2-(4-metil-fenil-sulfanil)-fenil]-piperidina, seu uso e composição farmacêutica compreendendo o referido composto | |
| BRPI0411268C8 (pt) | Processo para a preparação de compostos 3-aril butil-amina substituído | |
| PA8546301A1 (es) | Resolucion de sal quiral | |
| AR044706A2 (es) | Procedimientos para preparar 4-aminoquinolinas, inhibidores de cetp | |
| UA88767C2 (uk) | Ppar активні сполуки | |
| DK1651621T3 (da) | 2-(Quinoxalin-5-ylsulfonylamino)benzamidforbindelser som CCK2-modulatorer | |
| BRPI0615705A2 (pt) | processo para preparar um composto, e, composto | |
| RS52780B (en) | MEANS OF PREVENTION AND TREATMENT OF DISORDERS CONCERNING MODULATION OF RYR RECEPTORS | |
| NO20041339L (no) | Spiro-hydantoin-forbindelser anvendelige som anti-inflammatoriske midler | |
| DE602007004494D1 (de) | Herstellung von (2r,3r)-3-(3-methoxyphenyl)-n,n,2- trimethylpentanamin | |
| EA200800889A1 (ru) | Гексагидроциклооктилпиразольные каннабиноидные модуляторы | |
| ATE399775T1 (de) | Triphenylethyleneverbindungen als selektive modulatoren des östrogenrezeptors | |
| DK1210326T3 (da) | Hydroxamsyreforbindelser, der er nyttige som matrixmetalloproteinaseinhibitorer | |
| ITMI20050249A1 (it) | Procedimento per la preparazione di tolterodina | |
| BR9915868A (pt) | Processo para a decomposição de tramadol | |
| BR0007922A (pt) | Compostos calcilìticos | |
| BR0206964A (pt) | Diamidas de ácido ftálico, um processo para a sua preparação e sua aplicação como composições praguicidas | |
| TR199901017A2 (xx) | B�cek ilac� terkibi. | |
| BRPI0412721A (pt) | processo para preparar bromidrato de eletriptano alfa-polimórfico | |
| BR9916382A (pt) | Processo para a preparação de um composto | |
| DE602005020396D1 (de) | Haarfärbemittel enthaltend 2-Amino-3,5-substituierte Phenolverbindungen und deren Verwendung | |
| BRPI0614104A2 (pt) | compostos, processo para preparar compostos, agente fungicida, semente, e, processo para combater fungos nocivos fitopatogênicos | |
| CR8295A (es) | Procedimiento para preparar compuestos de 1-[ciano(fenil) metil]-ciclohexanol |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |